SRH Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-500
| Closed | -$4.49K | – | 271 |
|
2024
Q4 | $4.49K | Hold |
500
| – | – | ﹤0.01% | 250 |
|
2024
Q3 | $3.67K | Hold |
500
| – | – | ﹤0.01% | 261 |
|
2024
Q2 | $2.86K | Hold |
500
| – | – | ﹤0.01% | 270 |
|
2024
Q1 | $2.51K | Hold |
500
| – | – | ﹤0.01% | 292 |
|
2023
Q4 | $4.5K | Hold |
500
| – | – | ﹤0.01% | 258 |
|
2023
Q3 | $3.89K | Hold |
500
| – | – | ﹤0.01% | 256 |
|
2023
Q2 | $5.48K | Hold |
500
| – | – | ﹤0.01% | 240 |
|
2023
Q1 | $5K | Hold |
500
| – | – | ﹤0.01% | 244 |
|
2022
Q4 | $2K | Hold |
500
| – | – | ﹤0.01% | 276 |
|
2022
Q3 | $4K | Hold |
500
| – | – | 0.01% | 263 |
|
2022
Q2 | $5K | Hold |
500
| – | – | 0.01% | 246 |
|
2022
Q1 | $6K | Hold |
500
| – | – | 0.01% | 244 |
|
2021
Q4 | $11K | Sell |
500
-500
| -50% | -$11K | 0.01% | 210 |
|
2021
Q3 | $22K | Hold |
1,000
| – | – | 0.03% | 166 |
|
2021
Q2 | $13K | Hold |
1,000
| – | – | 0.02% | 196 |
|
2021
Q1 | $13K | Buy |
+1,000
| New | +$13K | 0.02% | 189 |
|